Literature DB >> 8949699

Neural tube defects 1974-94--down but not out.

M Murphy1, V Seagroatt, K Hey, M O'Donnell, M Godden, N Jones, B Botting.   

Abstract

AIMS: To describe accurately the total prevalence of neural tube defects (NTDs) in England and Wales over time, and to provide a benchmark up to 1994.
METHODS: National data about NTDs reported as births or terminations are available from 1974-94, but reporting is incomplete. A local register of NTDs covering Oxfordshire/west Berkshire from 1965-94 was used to validate national data for the locality, using the method of capture and recapture, and hence to estimate incompleteness of reporting nationally.
RESULTS: National underreporting is consistent at about two thirds of the true number of cases reaching at least the second trimester. The local register is much more complete, but time trends locally and nationally are similar. In England and Wales total prevalence declined from about 34 per 10000 live and stillbirths in 1974 to a plateau of just under 8 per 10000 in the 1990s.
CONCLUSIONS: The decline in NTD prevalence is real and seems to have stopped. How this relates to changes in diet or the practice of vitamin supplementation is unknown, and the implications of the plateau are uncertain. OPCS figures of 500 NTDs annually in England and Wales represent about two thirds of the true number of cases.

Entities:  

Mesh:

Year:  1996        PMID: 8949699      PMCID: PMC1061179          DOI: 10.1136/fn.75.2.f133

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  5 in total

1.  Prevalence of neural tube defects in South Australia, 1966-91: effectiveness and impact of prenatal diagnosis.

Authors:  A Chan; E F Robertson; E A Haan; R J Keane; E Ranieri; A Carney
Journal:  BMJ       Date:  1993-09-18

2.  Assessing the human condition: capture-recapture techniques.

Authors:  R E Laporte
Journal:  BMJ       Date:  1994-01-01

3.  Folic acid, pernicious anaemia, and prevention of neural tube defects.

Authors:  N J Wald; C Bower
Journal:  Lancet       Date:  1994-02-05       Impact factor: 79.321

4.  Use of local neural tube defect registers to interpret national trends.

Authors:  K Hey; M O'Donnell; M Murphy; N Jones; B Botting
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-11       Impact factor: 5.747

5.  Homocysteine metabolism in pregnancies complicated by neural-tube defects.

Authors:  J L Mills; J M McPartlin; P N Kirke; Y J Lee; M R Conley; D G Weir; J M Scott
Journal:  Lancet       Date:  1995-01-21       Impact factor: 79.321

  5 in total
  6 in total

1.  Neural tube defects and periconceptional folic acid in England and Wales: retrospective study.

Authors:  R A Kadir; C Sabin; B Whitlow; E Brockbank; D Economides
Journal:  BMJ       Date:  1999-07-10

2.  Lesson of the week: tethered cord syndrome after myelomeningocoele repair.

Authors:  N O Jeelani; T Jaspan; J A Punt
Journal:  BMJ       Date:  1999-02-20

3.  Preventing neural tube defects. Analysis is less than thorough.

Authors:  L Thorpe; P Lincoln
Journal:  BMJ       Date:  2000-07-15

4.  Similarities in the epidemiology of neural tube defects and coronary heart disease: is homocysteine the missing link?

Authors:  D H Stone; P McCarron; G D Smith
Journal:  J Epidemiol Community Health       Date:  1999-12       Impact factor: 3.710

5.  From arylamine N-acetyltransferase to folate-dependent acetyl CoA hydrolase: impact of folic acid on the activity of (HUMAN)NAT1 and its homologue (MOUSE)NAT2.

Authors:  Nicola Laurieri; Julien Dairou; James E Egleton; Lesley A Stanley; Angela J Russell; Jean-Marie Dupret; Edith Sim; Fernando Rodrigues-Lima
Journal:  PLoS One       Date:  2014-05-13       Impact factor: 3.240

6.  Women's Awareness of Periconceptional Use of Folic Acid Before and After Their Antenatal Visits.

Authors:  Mark Maher; Remon Keriakos
Journal:  Clin Med Insights Womens Health       Date:  2014-05-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.